Kamada to Announce Q3 and Nine Months Financial Results on November 10, 2025

Monday, Nov 3, 2025 7:02 am ET1min read

Kamada will announce Q3 and nine months financial results for September 30, 2025, on November 10, 2025. Management will host an investor call to discuss the results. The company's portfolio includes six FDA-approved specialty plasma-derived products and three plasma collection centers in the US. The company is also developing Inhaled AAT for areas of unmet medical need.

Kamada to Announce Q3 and Nine Months Financial Results on November 10, 2025

Comments



Add a public comment...
No comments

No comments yet